However, an anti-TNF-α treatment in SLE is questionable due to the development of antinuclear antibodies (ANA), anti-double-stranded DNA (anti-dsDNA) antibodies, and anticardiolipin antibodies [1]. Here, TNF is linked to systemic lupus erythematosus.